Chemical Biology, Molecular Mechanism and Clinical Perspective of &ggr; - Secretase Modulators in Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1875-6190|9|4|598-622

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.9, Iss.4, 2011-12, pp. : 598-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

&ggr;-Secretase as a Therapeutic Target for Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 661-670

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite

Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 3, 2006-06 ,pp. : 355-361

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Amyloid &bgr;-Protein and Its Associated Molecules in the Pathogenesis of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1075-1080

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of &bgr;-Amyloid Protein in Synaptic Function: Implications for Alzheimer's Disease Therapy

By  

Current Neuropharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 149-163

Bentham Science Publishers

Access to resources Recommend Favorite